2026
Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy.
This chapter focuses on the clinical applications of gapmer AOs for general dyslipidemia and lipodystrophy.
Tejal Aslesh, Toshifumi Yokota
· Methods in molecular biology · 0 citations